NEW YORK (GenomeWeb News) – Molecular Detection today said that Sydney, Australia-based Integrated Sciences has gained exclusive distribution rights in Australia to the firm's Detect-Ready MRSA assay.
Molecular Detection's Detect-Ready MRSA test is a qualitative real-time PCR-based test for the detection of methicillin-resistant Staphylococcus aureus nasal colonization. The test kits are off-the-shelf, room temperature-stabilized and are compatible with multiple rt-PCR platforms including the Roche LightCycler, Qiagen Rotor-Gene, and Cepheid SmartCycler, said Wayne, Pa.-based Molecular Detection.
The Detect-Ready MRSA assay kit already has the CE mark certification for sales in the European Union, and the test is currently sold in Germany, the UK, Spain, Ireland, Switzerland, and Austria.
Terms of the agreement were not disclosed.